logo-loader

Creo Medical patient on Speedboat cancer succcess

Published: 02:34 04 Aug 2025 EDT

Creo Medical Group PLC (AIM:CREO) has released a patient testimonial highlighting its Speedboat technology, after Liz Thomas avoided major bowel surgery by undergoing a minimally invasive procedure that used the device.

Previously unavailable through NHS Wales, Liz accessed the treatment privately in England and recovered within days.

The case underlines Speedboat’s clinical value for early colorectal cancer, allowing removal of pre-cancerous lesions without major surgery. The technology is being piloted in Wales by Aneurin Bevan University Health Board. Click here for the video.

Alvopetro posts 86% net back margin as Q2 volumes jump 26% and Murucututu...

Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) CEO Corey Ruttan tells Proactive's Stephen Gunnion that Q2 2026 sales volumes averaged 3,067 barrels of oil equivalent per day, up 26% year-on-year, with revenue of just over $19 million and funds flow from operations of $14.1...

22 hours, 56 minutes ago